| Active Ingredient | Alzocin Alfuzosin HCI & Dutasteride |
| Brand | Alzocin D |
| Country of origin | India |
| Form | Oral tablets |
Alzocin D 10mg/0.5mg is an Antispasmodic that helps in the treatment of Benign prostatic hyperplasia (BPH) or enlarged prostate gland in men. This combination medicine contains Alfuzosin and Dutasteride that helps improve urine flow and urination difficulties.
Clinical Uses
Alzocin D 10mg/0.5mg tablet is used to treat Benign prostatic hyperplasia that causes symptoms of difficulties in urination, weak urine stream, and frequent urination. It also helps with incomplete emptying of bladder or complete blockage of urine stream.
How It Works
Alzocin D 10mg/0.5mg is a combination of Alfuzosin (10mg) and Dutasteride (0.5mg). Alfuzosin is an alpha-blocker medicine that works by relaxing the muscles around the prostate and bladder improving urine flow.
Dutasteride is a 5-alpha-reductase inhibitor that reduces the hormone responsible for prostate growth helping in shrinking of the enlarged prostate gland.
Side Effects
Some of the side effects of Alzocin D 10mg/0.5mg Tablet include-
- Headache
- Dizziness
- Fatigue
- Common Cold
- Soar throat
- Drop in blood pressure upon standing up
- Inflammation of air passages in lungs
- Decreased libido
- Enlargement of breast or tenderness
- Erectile dysfunction
- Ejaculation disorder
Precautions & Warnings
- Alzocin D 10mg/0.5mg is not recommended for women and children.
- Inform your doctor if you have low blood pressure or kidney and liver disease.
- It is advisable to take the medicine consistently at the same time after the same meal for better results.
- Doctors advise to continue taking the medicine regularly as improvement of symptoms may take up to 4 weeks. Consult your doctor if symptoms persist or worsen after 4 weeks.
- Alzocin D 10mg/0.5mg may cause dizziness or weakness making it unsafe to drive or operate heavy machinery.
- This medicine can interact with alcohol potentially causing a sudden and dangerous drop in your blood pressure.
- Inform your doctor that you are taking Alzocin D 10mg/0.5mg if you are planning for any eye surgery.
- Do not donate blood while taking Alzocin D 10mg/0.5mg or for at least six months after your last dose.
Drug Interactions
Alzocin D 10mg/0.5mg tablets should be avoided with the following medications-
- Other Alpha-blocker medicines
- Sildenafil
- Tadalafil
- Blood pressure-lowering medicines
- Ketoconazole
- Itraconazole
- Ritonavir
- Idelalisib
- Clarithromycin
Note: This is not a complete list of all the possible drug interactions of Alzocin D 10mg/0.5mg tablets. Consult your doctor before taking any medicines or supplements with Alzocin D 10mg/0.5mg tablets.
Disclaimer
At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.
All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.
All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.
